As of the end of September, LIVZON PHARMA has repurchased a total of 15.3768 million A shares

Zhitong
2025.10.09 08:43
portai
I'm PortAI, I can summarize articles.

According to the Zhitong Finance APP, LIVZON PHARMA announced that as of September 30, 2025, the company repurchased a total of 15.3768 million A-shares through centralized bidding, accounting for 1.70% of the company's total share capital. The highest purchase price was RMB 41.99 per share, and the lowest price was RMB 33.21 per share, with a total amount of funds used being RMB 570 million (excluding transaction fees). The above repurchase is in line with the company's established share repurchase plan

According to the announcement from Zhitong Finance APP, LIVZON PHARMA (01513) has repurchased a total of 15.3768 million A-shares through centralized bidding trading as of September 30, 2025, accounting for 1.70% of the company's total share capital. The highest purchase price was RMB 41.99 per share, and the lowest price was RMB 33.21 per share, with a total amount of funds used being RMB 570 million (excluding transaction costs). The above repurchase is in line with the company's established share repurchase plan

Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
© 2025 Longbridge｜Disclaimer